Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study
Fateme Azimi, Jahan B. Ghasemi, Homa Azizian, et al.
International Journal of Biological Macromolecules (2020) Vol. 166, pp. 1082-1095
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Synthetic α-glucosidase inhibitors as promising anti-diabetic agents: Recent developments and future challenges
Alia Mushtaq, Uzma Azam, Saba Mehreen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115119-115119
Closed Access | Times Cited: 100
The inhibition mechanism of polyphenols from Phyllanthus emblica Linn. fruit on acetylcholinesterase: A interaction, kinetic, spectroscopic, and molecular simulation study
Min Wu, Ming Liu, Feiyang Wang, et al.
Food Research International (2022) Vol. 158, pp. 111497-111497
Closed Access | Times Cited: 41
Rational design, synthesis, in vitro, and in-silico studies of pyrazole‑phthalazine hybrids as new α‑glucosidase inhibitors
M. N. A. Md. Roshan, Roghieh Mirzazadeh, Azadeh Tajmir-Riahi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Design and synthesis of novel quinazolinone-pyrazole derivatives as potential α-glucosidase inhibitors: Structure-activity relationship, molecular modeling and kinetic study
Fateme Azimi, Homa Azizian, Mohammad Najafi, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105127-105127
Closed Access | Times Cited: 39
Chromone-based benzohydrazide derivatives as potential α-glucosidase inhibitor: Synthesis, biological evaluation and molecular docking study
Meiyan Fan, Wei Yang, Zhiyun Peng, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106276-106276
Closed Access | Times Cited: 32
Design, synthesis, in vitro α-glucosidase inhibition, docking, and molecular dynamics of new phthalimide-benzenesulfonamide hybrids for targeting type 2 diabetes
Mohammad Askarzadeh, Homa Azizian, Mehdi Adib, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Diaryl azo derivatives as anti-diabetic and antimicrobial agents: synthesis, in vitro, kinetic and docking studies
Tehreem Tahir, Mirza Imran Shahzad, Rukhsana Tabassum, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1508-1519
Open Access | Times Cited: 31
Synthesis of new diphenyl urea-clubbed imine analogs and its Implications in diabetic management through in vitro and in silico approaches
Anam Rubbab Pasha, Ajmal Khan, Saeed Ullah, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Fluorinated thiazole–thiosemicarbazones hybrids as potential PPAR-γ agonist and α-amylase, α-glucosidase antagonists: Design, synthesis, in silico ADMET and docking studies and hypoglycemic evaluation
Eman A. Fayed, A. Ben Thabet, Shimaa M. Abd El‐Gilil, et al.
Journal of Molecular Structure (2023) Vol. 1301, pp. 137374-137374
Closed Access | Times Cited: 11
Synthesis, Crystal Structure, Antioxidant Activity and Molecular Docking Studies of 2-(1-(3-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)ethyl)malononitrile
Rachid Bouzammit, Imane Lakkab, Mohamed El fadili, et al.
Journal of Molecular Structure (2024) Vol. 1312, pp. 138582-138582
Closed Access | Times Cited: 3
One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors
Malihe Karami, Alireza Hasaninejad, Hossein Mahdavi, et al.
Molecular Diversity (2021) Vol. 26, Iss. 5, pp. 2393-2405
Open Access | Times Cited: 28
Pyrazole scaffold‐based derivatives: A glimpse of α‐glucosidase inhibitory activity, SAR, and route of synthesis
Jannat ul Firdaus, Nadeem Siddiqui, Ozair Alam, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 5
Closed Access | Times Cited: 10
Pyrazoles as novel protein tyrosine phosphatase 1B (PTP1B) inhibitors: An in vitro and in silico study
Sónia Rocha, Mariana Lucas, Vera L. M. Silva, et al.
International Journal of Biological Macromolecules (2021) Vol. 181, pp. 1171-1182
Closed Access | Times Cited: 23
Design, synthesis, biological evaluation, and molecular modeling studies of pyrazole-benzofuran hybrids as new α-glucosidase inhibitor
Fateme Azimi, Homa Azizian, Mohammad Najafi, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Exploring of novel 4-hydroxy-2H-benzo[e][1,2]thiazine-3-carbohydrazide 1,1-dioxide derivative as a dual inhibitor of α-glucosidase and α-amylase: Molecular docking, biochemical, enzyme kinetic and in-vivo mouse model study
Saman Taj, Matloob Ahmad, Usman Ali Ashfaq
International Journal of Biological Macromolecules (2022) Vol. 207, pp. 507-521
Closed Access | Times Cited: 15
Synthesis and biological evaluation of novel isatin-hydrazide conjugates as potential antidiabetic agents
Rima D. Alharthy, Syeda Bakhtawar Zahra, Noor Fatima, et al.
Journal of Molecular Structure (2023) Vol. 1288, pp. 135783-135783
Closed Access | Times Cited: 8
Molecular properties and In silico bioactivity evaluation of (4-fluorophenyl)[5)-3-phen-(4-nitrophenyl yl-4,5-dihydro-1H-pyrazol-1-yl]methanone derivatives: DFT and molecular docking approaches
Ibrahim Asiata Omotayo, Banjo Semire, Oladuji T. Emmanuel, et al.
Journal of Taibah University Medical Sciences (2023) Vol. 18, Iss. 6, pp. 1386-1405
Open Access | Times Cited: 8
Structural, dynamic behaviour, in-vitro and computational investigations of Schiff’s bases of 1,3-diphenyl urea derivatives against SARS-CoV-2 spike protein
Saeed Ullah, Atta Ullah, Muhammad Waqas, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Discovery of novel thiazole derivatives containing pyrazole scaffold as PPAR-γ Agonists, α-Glucosidase, α-Amylase and COX-2 inhibitors; Design, synthesis and in silico study
Wael A.A. Fadaly, Ahmed Elshewy, Mohamed T. M. Nemr, et al.
Bioorganic Chemistry (2024) Vol. 152, pp. 107760-107760
Closed Access | Times Cited: 2
Synthesis of imidazole-pyrazole conjugates bearing aryl spacer and exploring their enzyme inhibition potentials
Faryal Chaudhry, Wardah Shahid, Mariya al-Rashida, et al.
Bioorganic Chemistry (2021) Vol. 108, pp. 104686-104686
Closed Access | Times Cited: 19
New quinoxalin‐1,3,4‐oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies
Roghieh Mirzazadeh, Mohammad Asgari, Ebrahim Barzegari, et al.
Archiv der Pharmazie (2021) Vol. 354, Iss. 9
Closed Access | Times Cited: 17
An Updated Overview of Synthetic α-glucosidase Inhibitors: Chemistry and Bioactivities
Yong-Si Cai, Hong-Xu Xie, Jinhe Zhang, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 26, pp. 2488-2526
Closed Access | Times Cited: 6
Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review
Faheem Hyder Pottoo, Alex Joseph, Subham Das, et al.
CNS & Neurological Disorders - Drug Targets (2021) Vol. 21, Iss. 10, pp. 940-951
Closed Access | Times Cited: 16
Design and synthesis of phenoxymethybenzoimidazole incorporating different aryl thiazole-triazole acetamide derivatives as α-glycosidase inhibitors
Anita Nasli Esfahani, Aida Iraji, Amir Alamir, et al.
Molecular Diversity (2021) Vol. 26, Iss. 4, pp. 1995-2009
Open Access | Times Cited: 16
Structure-Based Drug Design of Novel Piperazine Containing Hydrazone Derivatives as Potent Alzheimer Inhibitors: Molecular Docking and Drug Kinetics Evaluation
Abduljelil Ajala, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Brain Disorders (2022) Vol. 7, pp. 100041-100041
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top